AHLA Announces Dr. Indu Sabaiya as a Keynote Speaker for 2021 Annual Meeting
- May 19, 2021
AHLA announces Dr. Indu Sabaiya as a keynote speaker for 2021 Annual Meeting. Dr. Subaiya was named one of Health Information Technology’s Most Influential Women and is a visionary health care leader whose work builds community, creates dialogue, and inspires us to radically rethink how health shapes our lives. She is the Co-Founder and President of Catalyst @ Health 2.0.
Dr. Subaiya joins Dr. Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases and Christi A. Grimm, Principal Deputy Inspector General of the Department of Health and Human Services, Office of Inspector General as keynote speakers for AHLA’s 2021 Annual Meeting. Dr. Subaiya’s keynote address is generously sponsored by FTI Consulting.
“Dr. Subaiya’s address promises to provide a unique and thought-provoking perspective on how digital health is transforming the care delivery system,” comments Cynthia Y. Reisz, President-Elect of AHLA, “This is a can’t-miss event for all members of the health law community.”
Complimentary press registration is available for the Annual Meeting—see the program page for additional details.
About Dr. Indu Subaiya:
Dr. Subaiya is Co-founder and President of Catalyst @ Health 2.0, the industry leader in digital health strategic partnering, innovation competitions and programs for piloting and commercializing novel healthcare technologies. In 2007, Dr. Subaiya co-founded and served as CEO of Health 2.0, a global conference platform and community for the showcase and advancement of new technologies in healthcare. Health 2.0's conference business was acquired by HIMSS in 2017 and in the two years post acquisition, Dr. Subaiya headed the organization as Executive Vice President. She continues as Senior Advisor to HIMSS, providing thought leadership and content advisory services under the office of the Chief Technology and Innovation Officer. Dr. Subaiya is a female immigrant from India and is a passionate advocate for an end to healthcare disparities and for increased diversity across the leadership ranks of the industry.